Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Helichrysum italicum (Roth) G. Don and Helichrysum arenarium (L.) Moench Infusion Consumption Affects the Inflammatory Status and the Composition of Human Gut Microbiota in Patients with Traits of Metabolic Syndrome: A Randomized Comparative Study. β
Go to Publication β
Foods (Basel, Switzerland) (Foods ) Vol: 11 Issue 20 Pages: Pub: 2022 Oct 20 Epub: 2022 Oct 20 Authors Petelin A , Šik Novak K , Hladnik M , Bandelj D , Baruca Arbeiter A , Kramberger K , Kenig S , Jenko Pražnikar Z , |
|
|
Immortelle (Helichrysum italicum (Roth) G. Don) Essential Oil Showed Antibacterial and Biofilm Inhibitory Activity against Respiratory Tract Pathogens. β
Go to Publication β
Molecules (Basel, Switzerland) (Molecules ) Vol: 27 Issue 17 Pages: Pub: 2022 Aug 27 Epub: 2022 Aug 27 Authors Balázs VL , Filep R , Répás F , Kerekes E , Szabó P , Kocsis B , Böszörményi A , Krisch J , Horváth G , |
|
|
Immortelle (Helichrysum italicum (Roth) G. Don) Essential Oil Showed Antibacterial and Biofilm Inhibitory Activity against Respiratory Tract Pathogens. β
Go to Publication β
Molecules (Basel, Switzerland) (Molecules ) Vol: 27 Issue 17 Pages: Pub: 2022 Aug 27 Epub: 2022 Aug 27 Authors Balázs VL , Filep R , Répás F , Kerekes E , Szabó P , Kocsis B , Böszörményi A , Krisch J , Horváth G , |
|
|
Modifications of hydrophobicity, in vitro adherence and cellular aggregation of Streptococcus mutans by Helichrysum italicum extract. β
Letters in applied microbiology (Lett Appl Microbiol ) Vol: 38 Issue 5 Pages: 423-7 Pub: 2004 Epub: Authors Nostro A , Cannatelli MA , Crisafi G , Musolino AD , Procopio F , Alonzo V , |
|
|
Modifications of hydrophobicity, in vitro adherence and cellular aggregation of Streptococcus mutans by Helichrysum italicum extract. β
Letters in applied microbiology (Lett Appl Microbiol ) Vol: 38 Issue 5 Pages: 423-7 Pub: 2004 Epub: Authors Nostro A , Cannatelli MA , Crisafi G , Musolino AD , Procopio F , Alonzo V , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
